Lemonade’s Q2 2026 revenue climbed to $294.4 million, up $130.3 million, or 79%, from the second quarter of 2025, according to the letter to shareholders filed as an exhibit to its Form 8-K. In-force premium, the metric that most directly tracks the size of the book Lemonade actually underwrites, grew 32% year over year to $1.434 billion. The gap between those two figures is not a discrepancy — it is the story of a reinsurance structure that now keeps more of the same premium on Lemonade’s own books.
Why revenue grew more than twice as fast as premium
The mechanism sits in reinsurance economics, not in accounting choices. Lemonade attributes the increase primarily to growth in gross earned premium and a higher premium retention rate, due to reduced quota share cession rates that became effective in the third quarter of 2025 — a change that had been feeding through the book for three quarters before this one. Gross earned premium rose to $332.4 million in the quarter, from $252.3 million a year earlier, and because a smaller slice of that premium is now handed off, revenue rose faster than the premium base itself. Gross profit followed a similar pattern, reaching $113.2 million, up $48.9 million, or 76%, over the same period.
None of this required faster customer growth than Lemonade had already been posting. Total customers rose 23% year over year to 3,308,666, and premium per customer increased 8% to $433 — solid figures, but not enough on their own to fully explain a revenue increase of that scale. The mismatch between top-line growth and the underlying book is the fact any investor, broker or competing carrier should hold onto when reading Lemonade’s headline number.
| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Gross earned premium | $332.4 million | $252.3 million |
| In-force premium | $1,434.3 million | $1,083.4 million |
| Gross loss ratio | 60% | 67% |
| LAE ratio | 5% | 13% |
| Annual dollar retention | 85% | 84% |
| Net loss | $43.4 million | $43.9 million |
| Adjusted EBITDA loss | $18.7 million | $40.9 million |
The loss ratio and LAE ratio describe the operating improvement underneath
Strip away the reinsurance-driven revenue effect and Lemonade’s underwriting metrics still moved in the right direction on their own terms. The gross loss ratio improved to 60% in the quarter, from 67% a year earlier, and the loss-adjustment-expense ratio — the cost of handling claims as a share of premium — fell to a record low 5%, against an industry average of roughly 9%. Adjusted EBITDA loss narrowed to $18.7 million, from a $40.9 million loss in the second quarter of 2025, while the net loss came in at $43.4 million, or $0.56 per share, compared with a $43.9 million loss, or $0.60 per share, a year earlier. Those are underwriting and cost-control gains that a lower cession rate does not, by itself, manufacture.
That contrasts with how incumbent carriers are framing similar improvement this earnings season, as reflected in Travelers’ latest underwriting results — a reminder that scale still buys loss-ratio stability that a fast-growing insurtech has to earn one quarter at a time.
The Hannover Re facility and the bet on synthetic underwriting agents
Lemonade used the earnings release to confirm an extension of its synthetic-agents financing arrangement. The agreement with Hannover Re, effective January 2027, provides up to $250 million of outstanding capital to support future growth spend at roughly a 9.8% cost of capital. The insurer had already secured Hannover Re financing to fund its growth spend under the prior iteration of the program, and the renewal suggests both parties see the structure as durable rather than a one-off financing arrangement. Management paired that disclosure with guidance that it continues to expect positive Adjusted EBITDA in the fourth quarter of 2026, with third-quarter and full-year guidance implying roughly $8 million of positive Adjusted EBITDA in that quarter. If that guidance holds, the reinsurance renewal and the synthetic-agents extension will have moved in the same direction inside a single quarter: less premium ceded, and less growth capital raised through equity.
Retention, cash position and a CFO handoff round out the quarter
Lemonade closed the quarter with cash, cash equivalents and investments of approximately $1.2 billion, and annual dollar retention improved to 85%, from 84% a year earlier — a sign that growth is not coming at the expense of keeping existing policyholders. Separately, the company disclosed a leadership change: on July 27, 2026, the Board approved the transition of Tim Bixby from Chief Financial Officer to the Board, with Nick Stead appointed CFO effective January 1, 2027, a move detailed in a separate 8-K filing on the CFO transition. The transition was disclosed close on the heels of results that were themselves announced on July 29, 2026, covering the three and six months ended June 30, 2026, and it does not itself bear on the reinsurance or underwriting trends described above — but it lands at a moment when the market is being asked to read Lemonade’s numbers carefully.
What the reinsurance-driven number means for insurtech peers
The distinction between structural and organic growth is not a technicality for an audience of insurers, brokers and reinsurers pricing their own treaties. It is the difference between a company whose top line is flattered by a cession-rate change and one whose unit economics have genuinely improved — and Lemonade’s own Form 8-K for the quarter effectively argues for both at once. The record-low LAE ratio also sits inside a wider claims-automation narrative that insurtechs have leaned on this year, in which AI-labeled insurtechs claimed a record share of global funding earlier in the year, part of a broader pattern in which global insurtech funding accelerated in the same quarter. For competitors and reinsurers alike, the lesson is to read the cession rate before reading the revenue line.
